<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Neuronal <z:mpath ids='MPATH_3'>apoptosis</z:mpath> contributes to ischemic brain damage and <z:e sem="disease" ids="C0524851" disease_type="Disease or Syndrome" abbrv="">neurodegenerative disorders</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>Key regulators of neuronal <z:mpath ids='MPATH_3'>apoptosis</z:mpath> are the transcription factor NF-κB and the MAP kinases p38/MAPK and JNK, which share a common upstream activator, the <z:chebi fb="0" ids="52290">mitogen</z:chebi>-activated protein kinase kinase kinase (MAP3K) TGFβ-activated kinase 1 (TAK1) </plain></SENT>
<SENT sid="2" pm="."><plain>Here we investigate the function of TAK1 in <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e>-induced neuronal <z:mpath ids='MPATH_3'>apoptosis</z:mpath> </plain></SENT>
<SENT sid="3" pm="."><plain>In primary cortical neurons, TAK1 was activated by oxygen <z:chebi fb="105" ids="17234">glucose</z:chebi> deprivation (OGD), an in vitro model of <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> </plain></SENT>
<SENT sid="4" pm="."><plain>We found that short-term inhibition of TAK1 protected against OGD in vitro and reduced the <z:mpath ids='MPATH_124'>infarct</z:mpath> volume after middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp> in vivo </plain></SENT>
<SENT sid="5" pm="."><plain>Prolonged inhibition or deletion of the TAK1 gene in neurons was, however, not protective </plain></SENT>
<SENT sid="6" pm="."><plain>Short-term, but not prolonged inhibition of TAK1 interfered with the activation of p38/MAPK and JNK by OGD, the induction of the pro-oxidative genes Cox-2, Nox-2, and p40(phox), and the formation of <z:chebi fb="1" ids="18421">superoxide</z:chebi> </plain></SENT>
<SENT sid="7" pm="."><plain>We found that prolonged TAK1 inhibition upregulated another MAP3K, <z:mpath ids='MPATH_3'>apoptosis</z:mpath> signal-regulating kinase-1, which is able to compensate for TAK1 inhibition </plain></SENT>
<SENT sid="8" pm="."><plain>Our study demonstrates that TAK1 is a central target for short-term inhibition of key signaling pathways and neuroprotection in <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> </plain></SENT>
</text></document>